The dystrophin gene, which is defective in Duchenne muscular dystrophy (DMD), also encodes a number of smaller products controlled by internal promoters. Dp71, which consists of the two C-terminal domains of dystrophin, is the most abundant product of the gene in non-muscle tissues and is the major product in adult brain. To study the possible function of Dp71 and its expression during development, we specifically inactivated the expression of Dp71 by replacing its first and unique exon and a part of the concomitant intron with a β-galactosidase reporter gene. X-Gal staining of Dp71-null mouse embryos and tissues revealed a very stage-and cell type-specific activity of the Dp71 promoter during development and during differentiation of various tissues, including the nervous system, eyes, limb buds, lungs, blood vessels, vibrissae and hair follicles. High activity of the Dp71 promoter often seemed to be associated with morphogenic events and terminal differentiation. In some tissues the activity greatly increased towards birth.
INTRODUCTION
Duchenne muscular dystrophy (DMD) is an X-linked genetic disorder causing progressive muscle degeneration and death. A significant proportion of the affected children also suffer from cognitive impairments (reviewed in ref. 1) . The product of the huge (>2500 kb) and complex DMD gene in the muscle is dystrophin, a 427 kDa rod-shaped protein consisting of four major domains: an N-terminal actin-binding domain, a rodshaped domain consisting of 24 triple helix spectrin-like repeats, a cysteine-rich domain with two potential calcium-binding motifs and a unique C-terminal domain (2) . In the muscle dystrophin forms a link between cytoskeletal actin filaments and dystrophinassociated proteins (DAPs), a group of sarcolemmal proteins. One of the DAPs, α-dystroglycan, binds to a subunit of laminin, thus linking this complex and the extracellular matrix. Mutations in any of the proteins important for this linkage result in instability of muscle fibers, leading to muscular dystrophy (reviewed in refs 3, 4) .
The DMD gene also codes for two non-muscle isoforms of dystrophin, controlled by promoters located at the 5′-end of the gene; the brain type dystrophin (5) (6) (7) (8) and the Purkinje cell type dystrophin (9) . In addition, internal promoters located within introns further downstream in the huge DMD gene regulate the expression of four smaller proteins consisting of the C-terminal and cysteine-rich domains of dystrophin with various extensions into the spectrin-like repeats (10) (11) (12) (13) . One of these smaller proteins, Dp71, is of special interest. It is a 70.8 kDa protein, consisting of only the two C-terminal domains of dystrophin, and is the most ubiquitous product of the gene (10, 14 ; reviewed in ref. 15) . It is present at relatively high levels in all tissues tested so far, except for skeletal muscle. Its expression is regulated by a housekeeping type promoter located in intron 62 of the gene (16) (17) (18) .
In spite of its relative abundance and prevalence in non-muscle tissues, very little is known on the function of Dp71 as well as on that of the other non-muscle products of the DMD gene. It was shown that: (i) ectopic expression of Dp71 in the muscle of transgenic mdx mice lacking dystrophin restores the level of DAPs (which are depleted in the absence of dystrophin) to normal values; however, it cannot alleviate the muscle degeneration, indicating that Dp71 and dystrophin differ in their functions (19, 20) ; and (ii) deficiency of Dp71 is associated with reduced levels of DAPs in the brain, indicating that Dp71 is required for the organization or stabilization of the DAPs complexes in the brain (21; unpublished data). Recent reports showed association of Dp71 with DAPs such as β-dystroglycan (22), β-dystrobrevin (23) and syntrophin (24, 25) . It was shown that in muscle, the enzyme nitric oxide synthase (NOS) binds to syntrophin (26) . Thus, it is possible that in the brain and other non-muscle tissues, NOS forms a similar complex with syntrophin and Dp71. The product of NOS, nitric oxide, seems to play, among other things, an important role in synaptic transmission (reviewed in ref. 27 ).
So far, there are no known mutations in either human or in animal models which only affect the expression of Dp71. To further investigate the biological role of Dp71, we specifically inactivated its expression by homologous recombination, without interfering with expression of other products of the DMD gene. This was done by replacing part of the first and unique exon of Dp71 with a sequence encoding a β-galactosidase (β-gal)-neomycin resistance chimeric protein (β-geo). Homologous recombination abolished the expression of Dp71 and brought the expression of the inserted promoterless β-geo gene under the control of the Dp71 promoter. This enabled us to monitor with great sensitivity the activity of the promoter during development, using X-gal staining. The results show a complex pattern of regulated, tissue-and cell type-specific activity of the Dp71 promoter during embryonic development.
RESULTS

Specific inactivation of Dp71 by homologous recombination
The promoter and the first exon of Dp71 are located in intron 62 of the DMD gene. To specifically inactivate the expression of Dp71, we replaced by homologous recombination most of the first and unique exon of Dp71 and a small part of the Dp71 first intron with the promoterless β-geo gene (Fig. 1) .
Dp71 is expressed in cultured embryonic stem (ES) cells (28) . Since the DMD gene is located on chromosome X and the transfected ES cells were of male origin, we used western blot analysis to identify Dp71-null ES cell clones among the G418-resistant clones. Nine such clones were identified. Southern blot analysis confirmed that the loss of Dp71 expression in all Figure 2 . The homologous recombination abolishes Dp71 expression. Brain and muscle protein extracts from a Dp71 knockout mouse (ko), a wild-type littermate (wt) and an mdx 3CV mouse (3cv) having a mutation affecting all known products of the DMD gene (53) were analyzed by western blotting. The blots were stained with MANDRA1, a monoclonal antibody reacting with both dystrophin and Dp71. The trace of staining in the ko lane migrating similar to Dp71 is not specific since it was detected also when only the second Ab was used. M+B, rat muscle and brain extracts (∼1:1).
clones resulted from homologous recombination (data not shown).
The Dp71-null ES cell clones in which integration of only one copy of transfected DNA was confirmed by Southern blot analysis were used as donors for the production of chimeric mice. Four chimeric male mice, derived from different transfected ES cell clones, transmitted the recombinant gene to all their female progeny. Since the ES cells were hemizygous for the mutation, all first generation female progeny were heterozygous. Mating these females with the chimeras yielded homozygous progeny in the next generation. Identification of the homozygotes was done by western blotting and PCR analysis of tail proteins and DNA, respectively.
Western blot analysis of brain and muscle extracts of homozygote Dp71-null mice confirmed the specific inactivation of Dp71, with no effect on the expression of dystrophin (Fig. 2) .
β-Galactosidase staining revealed differential activity of the Dp71 promoter during development Regulation of the β-gal gene by the endogenous promoter of Dp71 permitted a more sensitive assay with a much higher resolution of Dp71 promoter activity than was previously possible. We therefore followed the expression of β-gal during embryogenesis by whole mount X-gal staining of embryos aged from 3.5 to 14.5 days post-coitum (d.p.c.).
Staining was not observed in 3.5 d.p.c. blastocysts, including in the inner cell mass (ICM), despite the expression of Dp71 in ICM-derived ES cells grown in culture (28) and the intense X-gal staining of the Dp71-null ES cells which were used for the production of the chimeras (data not shown).
Using dark field optics, a very faint staining was first detected in some late 8.5 d.p.c. embryos as two thin stripes in the dorso-lateral forebrain, in the junction of truncus arteriosus and in the forelimb buds (data not shown).
At 9.5 d.p.c. (Fig. 3A and B) prominent staining was observed in forelimb buds and in the forebrain and hindbrain. Staining in the forelimb buds was restricted to the mesoderm, where it was widespread but not uniform. Forebrain staining was widespread in the dorsal and lateral telencephali. In the hindbrain, strong staining was observed in the lateral neuroepithelium of rhombomere 6 ( Fig. 3A and B). Weak staining was observed in the ventral diencephalon of the forebrain and in the ventral midbrain/ hindbrain junction. Weak staining was also observed in somites at the level of the forelimb buds (Fig. 3A) . Histological analysis showed this to be non-uniform and restricted to dermomyotome (data not shown).
In 10.5 d.p.c. embryos, staining was also observed in the hindlimb bud mesoderm, dorsal telencephalic neuroepithelium and in some, but not all, cranial blood vessels. A ring of staining was observed at the junction of the truncus arteriosus and the heart. Weak patchy staining was seen in the ventral floor of the midbrain and hindbrain. The lateral staining in rhombomere 6 was not detected (data not shown).
By 11.5 d.p.c. the floor plate staining increased and extended from the mesencephalon into the caudal spinal cord (Fig. 3C ). In the brain, staining had receded from the more lateral portions of the telencephali, but remained strong in the dorsal and medial parts, mostly confined to the region of the developing hippocampus. Prominent staining was observed in portions of the developing vasculature and in dorsal non-neuron tissue between the hindbrain and the forelimb buds. Weaker staining was observed in the spinal ganglia in this same region and in the developing eye.
Whole mount staining of 13.5 d.p.c. homozygotes revealed a complex pattern of activity of the Dp71 promoter throughout the embryo (Fig. 3D) . Much of the staining observed in the 11.5 d.p.c. embryos was retained and became more intense, including staining in the developing hippocampus, spinal ganglia, dorsal cartilage mesenchyme, vasculature and eyes. Additional intense staining was observed in follicles of the developing vibrissae and the developing jaw and punctate staining was observed caudal to the liver (Fig. 3D) .
Embryos derived from different transfected ES cell clones gave essentially the same pattern of β-gal staining. There was, however, some variability in the intensity of staining even among embryos of the same litter. By 12.5 and 13.5 d.p.c. organogenesis and neurogenesis are well underway and these stages were chosen for a more detailed analysis. Serial sections of entire 12.5 and 13.5 d.p.c. whole mount stained embryos permitted more precise identification of stained cells. A prominent stripe of staining was observed in the ventral CNS (Fig. 4A ). In the rostral-caudal axis the staining extended from the cephalic flexure in the midbrain throughout the length of the spinal cord, largely co-extensive with the underlying notochord. This staining was restricted to the midline of the floor plate, extending from the ventricle through the marginal layer (Figs 4A and 5A) and exhibited a fine pattern of dorsal-ventral striations (Fig. 4A) . In the hindbrain, this staining corresponded to the medullary raphe. The punctate staining observed caudal to the liver in the whole mount embryos was in the developing pancreas (Fig. 4B) . The dorsal non-neural staining observed in the whole mount embryos was most intense in the mesenchymal cartilage primordium of the dorsal neural arch and loosely packed subarachnoid mesenchyme (Fig. 5A ). In the limb bud, staining was mostly found in the muscle or cartilage primordia, but weak staining was observed in the proximal ulna bone primordia (Fig.  5B ). In the developing vascular system staining was observed in parts of the arterial vasculature and was not correlated with arterial size or position. In the largest vessels, staining was mostly restricted to the tunica externa (Fig. 5C ). In the smaller vessels the entire endothelium was stained (Fig. 5D ). In the vibrissae follicles staining was intense and restricted to the differentiating cells of the hair buds and fibers (Fig. 5E) .
In the eye, the developing lens fiber cells stained intensely, whereas the adjacent anterior capsular epithelial cells at the lens margin did not ( Fig. 5F and G) . The elongated lens fibers at this stage are intensely engaged in the production of crystallins and other lens proteins. The inner layer of the developing retina and the marginal zone of the optic cup were also stained. At this stage, the differentiated layers of the mature retina are not yet developed; however, in the retina of 1-month-old mice the blue staining was restricted mostly to the ganglion cell layer and the layer of the optic nerve fibers (data not shown). Interestingly, D'Souza et al. (13) and Kameya et al. (29) showed by immunostaining that the retina-specific product of the DMD gene Dp260 (13) is localized in the outer plexiform layer of the retina. This indicates that the patterns of expression of Dp71 and Dp260 in the retina are different. This may suggest that the two proteins have different functions in the retina. Significant blue staining was also detected in the pigmented epithelium in eyes of albino unpigmented embryos (Fig. 5F) . A difference in localization in the retina between Dp71 and Dp260, observed by immunostaining, was recently reported also by Howard et al. (30) .
Sectioning revealed additional sites of expression that were not readily identifiable in the whole mount staining. In the head region, additional neuroepithelial staining was observed in the developing olfactory bulb (Fig. 4A ) and in the infundibulum of the pituitary. Portions of the vomeronasal organs, the trigeminal ganglia and the cochlear canals were stained (Fig. 4B) . In the jaw region, mesoderm in the vertical palatine process and portions of epithelially derived dental laminae were stained (Fig. 4B) . Staining was also observed in the genital tubercles (data not shown). Additional, less intense and local patchy staining was observed in mesenchyme and ectoderm throughout the body.
Whole mount 14.5 d.p.c. embryos had lost much of the staining in the developing limb, whereas staining in the spinal ganglia increased in intensity. Strong staining was still apparent in the vibrissae and the lens and additional staining was observed in hair follicles of the trunk, abdomen and tail epidermis (data not shown).
As mentioned, Dp71 has a housekeeping type promoter. Consistent with this, western blot analysis revealed Dp71 in all non-muscle tissues tested so far (14, 21) . The observed high specificity of X-gal staining does not exclude the existence of a low level of ubiquitous activity of the Dp71 promoter that was not detected by X-gal staining.
Increased staining in late fetuses and newborns
At later stages, including newborn and adult mice, specific tissues were dissected and stained in whole mount format. Weak staining was observed in lung tissue at 16.5 d.p.c. Staining intensity was variable between embryos but was always restricted to the bronchi. The intensity of this staining greatly increased during the following 2 days (Fig. 6A-C) . In neonates and adults, the bronchi stained very strongly in all samples (Fig. 6C) In (A) staining is observed in the telencephalon (te), medullary raphe (mr), olfactory bulb (ob) and floor plate (fp). In (B) staining is observed in the telencephalon (te), dorsal root ganglia (drg), palatine process (pp), cochlea (c), adrenal (ad) and pancreatic primordia (p). and adult lungs showed that staining remained restricted to the bronchial epithelium ( Fig. 6D and E) .
A strong perinatal increase in staining was also observed in the brain (Fig. 7A and B) . Whereas staining in the brain was mainly restricted to a few specific locations during embryonic development, the neonatal and adult brain exhibited widespread intense staining (Fig. 7B) . Cross-sections showed particularly intense staining in the hippocampus and in some layers of cerebral cortex (data not shown).
DISCUSSION
Previous studies, using protein and RNA assays, showed that Dp71 is the major product of the DMD gene in a variety of adult tissues. Unlike dystrophin, the largest product of the DMD gene, which is essential for maintaining the integrity of functional muscle fibers, Dp71 is not expressed in adult muscle. In spite of its wide distribution in the adult tissues, the function of Dp71 remains unknown.
To gain an insight into the function of Dp71, we used the knock-in of a β-gal reporter gene to follow the activity of the Dp71 promoter during mouse embryonic development. Previous work using in situ hybridization had shown that Dp71 mRNA is expressed in the forebrain and neural tube floor plate, vibrissae follicles and teeth primordia. Low expression was also detected in the lungs and liver of developing embryos (31, 32) . Gorecki and Barnard (33) detected a strong signal in the dentate gyrus and a much weaker signal in the cerebral cortex and olfactory bulb of adult animals. Due to the high sensitivity and resolution of X-gal staining, we were able to examine the activity of the Dp71 promoter in much greater detail than was previously possible. We observed, for the first time, staining in the limb buds, pituitary, adrenals, lens and retina, the inner ear and nasal organ, blood vessels, rhombomere 6 of the hindbrain and somites. The high sensitivity also enabled us to detect staining as early as 8.5 d.p.c., compared with 11.5 d.p.c. observed by in situ hybridization.
Our studies indicate that the expression of Dp71 during development is complex and dynamic. From early organogenesis to adult, X-gal staining was observed in various tissues and cell types derived from all three germ layers. So far, we have not discerned a common theme that unites all observations. However, high Dp71 promoter activity was often correlated with terminal differentiation. This was most clearly seen in the developing eye lens and hair follicles. In both of these tissues, final differentiation is a continuous, spatially ordered process. In the lens of the eye, the anterior capsular epithelial cells at the margin differentiate medially into elongated, crystallin-producing lens cells (see for example ref. 34 ). The onset of intense staining was abrupt and accompanied the cell elongation (Fig. 5G) . Similarly, in the vibrissae, the cells of the dermal papilla continuously differentiate into the keratin-producing hair bud and hair fiber cells. Staining was absent in the undifferentiated dermal papillae, but strong in the hair bud and shaft cells. The staining weakened or was absent in the distal hair shaft, probably due to the eventual inactivation of the Dp71 promoter and β-gal expression as the cells become inactive and die (Fig. 5E) . Similarly, staining observed in the bronchi may also accompany terminal differentiation. The lungs mature only very late in development (34) and we observed a dramatic increase in staining in the lung starting at 17.5 d.p.c. This staining was restricted to bronchial epithelial cells ( Fig. 6D and  E) . The staining observed in the developing vasculature may also occur during differentiation. The circulatory system is one of the first systems in the embryo to functionally differentiate and we have observed very early staining in blood vessels.
Another observation is the very high activity of the Dp71 promoter during development of the central and peripheral nervous system. The increase in staining observed in the perinatal brain may accompany an increase in brain activity chronologically associated with birth.
Interestingly, there is a substantial correlation between Dp71 expression and expression of the vertebrate hedgehog gene family. The three members of the hedgehog family, Sonic, Desert and Indian hedgehog, are expressed in many of the same tissues as Dp71, including the neural tube floor plate, limb bud, vibrissae and hair, tooth, endothelium and lung (35, 36) . As was noted in these studies, expression was typically found in developmental processes involving mesenchymal-epithelial interactions. In the case of the hedgehog signalling molecules, a functional role in mediating the interaction was suggested. The much later onset of Dp71 expression suggests that it does not play a role in the mesenchymal-epithelial interactions, but that perhaps the initi- ation of Dp71 expression is a downstream result of the hedgehog signalling pathway.
The present study indicates an intimate association between Dp71 expression and many processes during development. Nevertheless, in our preliminary examination we have not yet detected conspicuous morphological or histological abnormalities in Dp71-null mice. The mice were viable, fertile and exhibited no obvious abnormalities in general appearance and development, when compared with wild-type and littermate heterozygote (until at least the age of 6 months). However, a more detailed analysis is required.
Since the location of the Dp71 promoter is in intron 62 in the 3′-region of the DMD gene, most of the mutations in the DMD gene are located 5′ of this region and do not affect the production of Dp71. There are indications that in humans severe mental retardation is more frequently associated with mutations that also affect the production of Dp71, suggesting the involvement of Dp71 in brain function (37, 38) . We have shown that the area of . We continue to examine the Dp71-null mice for abnormalities, with particular attention directed towards the CNS and behavior.
Dp71 consists of the two C-terminal domains of dystrophin. These two domains are present, with some small variations caused by alternative splicing, in all other known products of the DMD gene. They are also the most evolutionarily conserved regions in dystrophin-related proteins encoded by other genes (40) (41) (42) . Therefore, we are investigating the possibility that in Dp71-null mice, the lack of Dp71 is at least partially compensated for by another product of the DMD gene or by a dystrophin-related protein.
The partial compensation for lack of dystrophin by utrophin was recently demonstrated in the muscle of mdx mice (43) (44) (45) .
Wertz and Fuchtbaner (46) reported very recently on random insertion of the β-geo gene into exon 63 of the DMD gene. This insertion mutated all known DMD gene products and the β-gal activity in these mice is expected to report the expression of all these products. Yet, the general pattern of X-gal staining in non-muscle tissues was similar to that observed in the present experiments in which the staining reports only the activity of the promoter of Dp71. This reflects, most probably, the fact that Dp71 is the major product of the gene in non-muscle tissues. The similarities in the patterns of X-gal staining obtained by inserting the β-gal gene into two different locations support the conclusion that the X-gal staining in the Dp71-null mice reflects the genuine activity of the endogenous Dp71 promoter.
MATERIALS AND METHODS
Construction of the targeting vector
The promoter region of Dp71 was isolated from a genomic DNA library of 129 SVJ mice (Stratagene).
For making the targeting construct (pKSDp71β-geo) we used a promoterless gene encoding a β-gal-neomycin resistance chimeric protein (β-geo), derived from the plasmid pSAβ-geo (47) . As detailed elsewhere (manuscript in preparation), we inserted 5′ of the β-geo gene a 1.8 kb fragment ending at a HindIII site in the unique first exon of Dp71. We inserted a 4 kb fragment starting at a SmaI site in the beginning of the Dp71 first intron 3′ of the β-geo gene. Thus, a homologous recombination event should result in replacement of most of the first exon of Dp71 and a small part of the first intron of Dp71 with the β-geo gene (Fig. 1) .
Cell lines
Cultures of the R1 ES cell line derived from mouse strain 129/sv × 129/sv-cp (obtained from Dr A.Nagy) were grown on a feeder layer of irradiated fibroblasts from 14 d.p.c. embryos (48) . The ES medium (49) contained leukemia inhibitory factor (LIF) that was prepared as described by Mereau et al. (50) . The appropriate dilution was determined by the inhibitory effect of LIF on the differentiation of the cells.
Electroporation and selection of transfected ES cell clones
R1 cells (one confluent 10 cm plate) from passage 13 were mixed with 30 µg of the targeting plasmid, pKSDp71β-geo, cut with Not1 and Kpn1 in phosphate-buffered saline (PBS) and electroporated using a Bio-Rad Gene Pulser (0.25 kV, 500 µF). The neomycin derivative G418 (350 µg/ml) was added to the medium after 1 day. After 10-11 days, colonies were isolated. Each colony was divided into two; one part was expanded and used for characterization of the clone; the second part was kept frozen at -80_C.
Western blot analysis
Cultures of G418-resistant clones were harvested in electrophoresis sample buffer. The proteins were size fractionated on a 3-10% gradient polyacrylamide-SDS gel, transferred to nitrocellulose membrane and immunostained with MANDRA1, a monoclonal antibody raised against the C-terminal domain of human dystrophin (14, 51) . Tails and tissues were homogenized in the electrophoresis sample buffer and analyzed with the same antibody.
Production of chimeras and knockout mice
Chimeric embryos were produced as described by Hogan et al. (48) . Eight to 10 ES recombinant cells were aggregated with morulas collected from MF-1 superovulated mice and implanted into pseudopregnant females. Since MF-1 is an albino strain and the ES cells originated from 129/sv × 129/sv-cp matings, the chimeras were recognized by their pigmentation.
X-Gal staining
Recombinant ES cells were washed with PBS, fixed in PBS containing 4% paraformaldehyde (PFA) for 3 min, washed three times with PBS and stained overnight at 37_C with X-gal (52) .
Post-implantation embryos were recovered at the appropriate stages, the day of the plug being considered as day 0.5 of development. Embryos and whole organs were washed in PBS, fixed for 30-90 min (according to their size) in 4% PFA and stained overnight with X-gal. Sodium desoxycholate (0.01%) and NP-40 (0.02%) were added to the staining buffer. After staining, embryos were washed in PBS and were dehydrated in ethanol (30, 50, 80 and 100% ethanol) . Where indicated, dehydrated embryos were cleared in benzyl alcohol:benzylbenzoate (BABB) solution (1:2).
For sectioning, stained embryos were post-fixed overnight in 4% PFA, dehydrated, embedded in paraffin and cut on a microtome. The slices were deparafinized with xylene (2 min), rehydrated (from 95 to 25% ethanol), counterstained with nuclear fast red (3 min), dehydrated again and mounted with entellan.
